2m 2m 2m 2m 2m 2m 2m
NOVAVAX (NVAX)
NASDAQ
$7.39+$0.06 (+0.89%)
Price as of Aug 03, 2026 9:02 AM EDT- $1.2BMarket Cap
- 11.59%1-Year Change
- BiotechnologyIndustry
NOVAVAX (NVAX)
$7.39+$0.06 (+0.89%)
NVAX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.32 | ||
Change | -$0.12 (-1.61%) | ||
Open | $7.44 | ||
High | $7.49 | ||
Low | $7.21 | ||
Previous Close | $7.44 | ||
Volume | 3,405,997 | ||
30-Day Average Volume | 3,270,339 | ||
1-Week Change | -1.88% | ||
1-Month Change | -22.29% | ||
1-Year Change | 11.59% | ||
3-Year Change | -21.12% | ||
5-Year Change | -95.92% | ||
Fundamentals | |||
Shares Outstanding | 164.4M | ||
Total Assets | $1.0B | ||
Market Cap | $1.2B | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | $42.2M | ||
Net Income | -$9.5M | ||
Free Cash Flow | -$33.7M | ||
EBIT | -$4.8M | ||
EBITDA | -$1.7M | ||
Net Working Capital | $508.4M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -744 | ||
Enterprise Value/Revenue | 30 | ||
P/B | -8 | ||
P/E | -122 | ||
PEG | 1 | ||
Price/Free Cash Flow | -36 | ||
Price/Operating Cash Flow | -37 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 12/13/2007 | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 05/10/2019 | ||
Earnings & Revenue